scPharmaceuticals Inc. Profile Avatar - Palmy Investing

scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through…

Biotechnology
US, Burlington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

scPharmaceuticals Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SCPH's Analysis
CIK: 1604950 CUSIP: 810648105 ISIN: US8106481059 LEI: - UEI: -
Secondary Listings
SCPH has no secondary listings inside our databases.